tirzepatide and alcohol addiction attenuates dopamine reward signaling suppresses drinking and relapse-like behaviors in rodents Tirzepatide Interaction with Alcohol: Safety

For someone starting at 200 pounds, this translates to approximately 30-34 pounds

Limitations An editorial accompanying the article noted some limitations of the trial (Ref 9)

Your program evolves as your metabolism and hormone levels respond to treatment keeping your results on track from your first consultation through every stage of your care

Other diabetes medication classes offer alternatives if GLP-1 therapy proves unsuitable: SGLT2 inhibitors (such as dapagliflozin or empagliflozin) provide cardiovascular and renal benefits without affecting gastric emptying, though require adequate renal function and carry risks of genital infections and diabetic ketoacidosis DPP-4 inhibitors (such as sitagliptin) work on the incretin system but with less pronounced gastrointestinal effects note these should not be combined with GLP-1 receptor agonists Traditional agents including metformin, sulfonylureas, or insulin may be appropriate depending on individual circumstances Any medication change should be made in consultation with your diabetes specialist or GP, considering your overall glycaemic control, cardiovascular risk profile, and treatment goals, in line with NICE NG28 guidance

As weight decreases, the body often fights back by increasing appetite hormones and lowering energy use